Nicholas Khadder's most recent trade in Cooper Companies, Inc. was a trade of 8,578 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 10, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cooper Companies, Inc. | Nicholas Khadder S. | VP, General Counsel & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 8,578 | 8,578 | - | - | Restricted Stock Units | |
| Cooper Companies, Inc. | S. Khadder Nicholas | VP, General Counsel & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2024 | 284 | 853 | - | - | Restricted Stock Units | |
| Cooper Companies, Inc. | Nicholas S. Khadder | VP, General Counsel & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2024 | 284 | 324 (0%) | 0% | 0 | Common Stock | |
| Cooper Companies, Inc. | Khadder Nicholas S. | VP, General Counsel & Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 373.57 per share. | 08 Jan 2024 | 116 | 208 (0%) | 0% | 373.6 | 43,334 | Common Stock |
| Cooper Companies, Inc. | S. Nicholas Khadder | VP, General Counsel & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 2,351 | 2,351 | - | - | Restricted Stock Units | |
| Cooper Companies, Inc. | Nicholas S. Khadder | VP, General Counsel & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 3,635 | 3,635 | - | - | Stock Options (Right to Buy) | |
| Cooper Companies, Inc. | Nicholas S. Khadder | VP, General Counsel & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 1,137 | 1,137 | - | - | Restricted Stock Units | |
| Cooper Companies, Inc. | Nicholas S. Khadder | VP, General Counsel & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 3,159 | 3,159 | - | - | Stock Options (Right to Buy) | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 31 May 2022 | 3,341 | 100,480 (0%) | 0% | 1.6 | 5,369 | Common Stock |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 15,000 | 15,000 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 15,000 | 101,454 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 20 May 2022 | 14,161 | 97,139 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 9,846 | 29,541 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 9,846 | 111,300 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 4,063 | 32,500 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 4,063 | 86,454 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 4,062 | 36,563 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 4,062 | 84,660 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.62 per share. | 22 Feb 2022 | 2,269 | 82,391 (0%) | 0% | 3.6 | 8,214 | Common Stock |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2022 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2021 | 4,063 | 81,249 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2021 | 4,063 | 40,625 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.49 per share. | 20 Nov 2021 | 2,014 | 79,235 (0%) | 0% | 4.5 | 9,043 | Common Stock |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 4,062 | 79,199 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 4,062 | 44,688 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.53 per share. | 20 Aug 2021 | 2,013 | 77,186 (0%) | 0% | 6.5 | 13,145 | Common Stock |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 30,000 | 96,918 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.52 per share. | 20 May 2021 | 22,838 | 74,080 (0%) | 0% | 5.5 | 126,066 | Common Stock |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 16,250 | 48,750 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 16,250 | 66,918 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Nicholas Khadder | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2021 | 39,387 | 39,387 | - | - | Restricted Stock Units |